Intracardiac Thrombosis Due to Antiphospholipid Syndrome
Authors : Nurullah TÜZÜN, Efe EDEM, Mustafa Türker PABUCCU
Pages : 201-203
View : 14 | Download : 8
Publication Date : 2016-12-01
Article Type : Other Papers
Abstract :Normal 0 false false false TR JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:`Table Normal`; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:``; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Cambria; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin;} Antiphospholipid syndrome insert ignore into journalissuearticles values(APS); is an autoimmune disease characterised by arterial and venous thrombosis. Recurrent thrombosis and pregnancy losses are important in its diagnosis. Due to the risk of recurrence of thrombosis, long-term anticoagulant treatment may be required. Here, we present the case of a patient who suffered from intracardiac thrombosis due to APS. At present, treatment for significant thrombotic events in patients with APS, such as the aforementioned intracardiac thrombosis, is generally lifelong.Keywords : Antiphospholipid syndrome, intracardiac thrombosis